These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. McCune MA; Perry HO; Muller SA; O'Fallon WM Cutis; 1984 Oct; 34(4):366-73. PubMed ID: 6435961 [TBL] [Abstract][Full Text] [Related]
18. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE; J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183 [TBL] [Abstract][Full Text] [Related]
20. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group. Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]